- Home
- JAKK vs ELDN Comparison
JAKK vs ELDN Comparison
Compare JAKK & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- ELDN
- Stock Information
- Founded
- JAKK 1995
- ELDN 2004
- Country
- JAKK United States
- ELDN United States
- Employees
- JAKK N/A
- ELDN N/A
- Industry
- JAKK Recreational Games/Products/Toys
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- JAKK Consumer Discretionary
- ELDN Health Care
- Exchange
- JAKK Nasdaq
- ELDN Nasdaq
- Market Cap
- JAKK 231.8M
- ELDN 202.4M
- IPO Year
- JAKK 1996
- ELDN N/A
- Fundamental
- Price
- JAKK $17.88
- ELDN $2.42
- Analyst Decision
- JAKK Strong Buy
- ELDN Strong Buy
- Analyst Count
- JAKK 4
- ELDN 2
- Target Price
- JAKK $40.25
- ELDN $12.50
- AVG Volume (30 Days)
- JAKK 82.1K
- ELDN 664.2K
- Earning Date
- JAKK 10-29-2025
- ELDN 11-11-2025
- Dividend Yield
- JAKK 5.61%
- ELDN N/A
- EPS Growth
- JAKK 25.15
- ELDN N/A
- EPS
- JAKK 3.34
- ELDN 0.21
- Revenue
- JAKK $684,694,000.00
- ELDN N/A
- Revenue This Year
- JAKK N/A
- ELDN N/A
- Revenue Next Year
- JAKK $4.01
- ELDN N/A
- P/E Ratio
- JAKK $5.33
- ELDN $11.41
- Revenue Growth
- JAKK 1.31
- ELDN N/A
- 52 Week Low
- JAKK $16.24
- ELDN $2.38
- 52 Week High
- JAKK $35.79
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- JAKK 50.93
- ELDN 36.00
- Support Level
- JAKK $17.27
- ELDN $2.57
- Resistance Level
- JAKK $18.00
- ELDN $2.84
- Average True Range (ATR)
- JAKK 0.37
- ELDN 0.13
- MACD
- JAKK 0.06
- ELDN 0.01
- Stochastic Oscillator
- JAKK 48.80
- ELDN 1.18
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.